SYRE
SYRE
US00773J2024
Spyre Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.01B EUR
7.82B EUR
3.98B EUR
2.56B EUR
Enterprise Value
6.05B EUR
7.66B EUR
3.88B EUR
2.48B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-24.34x
--
--
--
Price to Sales
--
--
--
--
Price to Book
7.9x
7.1x
5.93x
3.58x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.11%
-2.67%
-4.67%
-5.01%
ende